RetroSense Therapeutics Selected As Finalist For Prestigious Angel Investor Award

ANN ARBOR, Mich.--(BUSINESS WIRE)--RetroSense Therapeutics LLC., a privately-held biopharmaceutical company, today announced that it has been selected as a finalist for the Luis Villalobos Award sponsored by the Angel Capital Association. The winner will be announced at the 2015 ACA Summit in San Diego on April 15, 2015. Named in memory of angel investor Luis Villalobos, the award recognizes startup innovation and ingenuity.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC